Footprints of Antigen Processing Boost MHC Class II Natural Ligand Predictions

Overview

Journal Genome Med

Publisher Biomed Central

Specialty Genetics

Date 2018 Nov 18

PMID 30446001

Citations 46

Authors

Carolina Barra

Bruno Alvarez

Sinu Paul

Alessandro Sette

Bjoern Peters

Massimo Andreatta

Soren Buus

Morten Nielsen

Affiliations

Soon will be listed here.

Abstract

Background: Major histocompatibility complex class II (MHC-II) molecules present peptide fragments to T cells for immune recognition. Current predictors for peptide to MHC-II binding are trained on binding affinity data, generated in vitro and therefore lacking information about antigen processing.

Methods: We generate prediction models of peptide to MHC-II binding trained with naturally eluted ligands derived from mass spectrometry in addition to peptide binding affinity data sets.

Results: We show that integrated prediction models incorporate identifiable rules of antigen processing. In fact, we observed detectable signals of protease cleavage at defined positions of the ligands. We also hypothesize a role of the length of the terminal ligand protrusions for trimming the peptide to the MHC presented ligand.

Conclusions: The results of integrating binding affinity and eluted ligand data in a combined model demonstrate improved performance for the prediction of MHC-II ligands and T cell epitopes and foreshadow a new generation of improved peptide to MHC-II prediction tools accounting for the plurality of factors that determine natural presentation of antigens.

Citing Articles

3D genome contributes to MHC-II neoantigen prediction.

Feng M, Liu L, Su K, Su X, Meng L, Guo Z BMC Genomics. 2024; 25(Suppl 2):889.

PMID: 39327585 PMC: 11425871. DOI: 10.1186/s12864-024-10687-3.

In Silico Tools for Predicting Novel Epitopes.

Barra C, Nilsson J, Saksager A, Carri I, Deleuran S, Garcia Alvarez H Methods Mol Biol. 2024; 2813:245-280.

PMID: 38888783 DOI: 10.1007/978-1-0716-3890-3_17.

Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity.

Thrift W, Perera J, Cohen S, Lounsbury N, Gurung H, Rose C Brief Bioinform. 2024; 25(3).

PMID: 38555476 PMC: 10981672. DOI: 10.1093/bib/bbae123.

Structure-aware deep model for MHC-II peptide binding affinity prediction.

Yu Y, Zu L, Jiang J, Wu Y, Wang Y, Xu M BMC Genomics. 2024; 25(1):127.

PMID: 38291350 PMC: 10826266. DOI: 10.1186/s12864-023-09900-6.

New light on the HLA-DR immunopeptidomic landscape.

Jensen E, Reynisson B, Barra C, Nielsen M J Leukoc Biol. 2024; 115(5):913-925.

PMID: 38214568 PMC: 11057780. DOI: 10.1093/jleuko/qiae007.

References

Nielsen M, Lundegaard C, Lund O . Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics. 2007; 8:238. PMC: 1939856. DOI: 10.1186/1471-2105-8-238. View

Kreiter S, Vormehr M, van de Roemer N, Diken M, Lower M, Diekmann J . Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015; 520(7549):692-6. PMC: 4838069. DOI: 10.1038/nature14426. View

Sidney J, Southwood S, Moore C, Oseroff C, Pinilla C, Grey H . Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture. Curr Protoc Immunol. 2013; Chapter 18:Unit 18.3.. PMC: 3626435. DOI: 10.1002/0471142735.im1803s100. View

Lanzarotti E, Marcatili P, Nielsen M . Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring. Mol Immunol. 2017; 94:91-97. PMC: 5800965. DOI: 10.1016/j.molimm.2017.12.019. View

Blum J, Wearsch P, Cresswell P . Pathways of antigen processing. Annu Rev Immunol. 2013; 31:443-73. PMC: 4026165. DOI: 10.1146/annurev-immunol-032712-095910. View

Andreatta M, Jurtz V, Kaever T, Sette A, Peters B, Nielsen M . Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules. Immunology. 2017; 152(2):255-264. PMC: 5588850. DOI: 10.1111/imm.12763. View

Vita R, Overton J, Greenbaum J, Ponomarenko J, Clark J, Cantrell J . The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 2014; 43(Database issue):D405-12. PMC: 4384014. DOI: 10.1093/nar/gku938. View

Buus S, Sette A, Colon S, Miles C, Grey H . The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 1987; 235(4794):1353-8. DOI: 10.1126/science.2435001. View

Tran E, Turcotte S, Gros A, Robbins P, Lu Y, Dudley M . Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science. 2014; 344(6184):641-5. PMC: 6686185. DOI: 10.1126/science.1251102. View

10.

Andreatta M, Alvarez B, Nielsen M . GibbsCluster: unsupervised clustering and alignment of peptide sequences. Nucleic Acids Res. 2017; 45(W1):W458-W463. PMC: 5570237. DOI: 10.1093/nar/gkx248. View

11.

Godkin A, Smith K, Willis A, Tejada-Simon M, Zhang J, Elliott T . Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J Immunol. 2001; 166(11):6720-7. DOI: 10.4049/jimmunol.166.11.6720. View

12.

Lippolis J, White F, Marto J, Luckey C, Bullock T, Shabanowitz J . Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol. 2002; 169(9):5089-97. DOI: 10.4049/jimmunol.169.9.5089. View

13.

Sette A, Adorini L, Colon S, Buus S, Grey H . Capacity of intact proteins to bind to MHC class II molecules. J Immunol. 1989; 143(4):1265-7. View

14.

Kim A, Hartman I, Poore B, Boronina T, Cole R, Song N . Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nat Commun. 2014; 5:5369. PMC: 4241505. DOI: 10.1038/ncomms6369. View

15.

Ciudad M, Sorvillo N, van Alphen F, Catalan D, Meijer A, Voorberg J . Analysis of the HLA-DR peptidome from human dendritic cells reveals high affinity repertoires and nonconventional pathways of peptide generation. J Leukoc Biol. 2016; 101(1):15-27. DOI: 10.1189/jlb.6HI0216-069R. View

16.

Hobohm U, Scharf M, Schneider R, Sander C . Selection of representative protein data sets. Protein Sci. 1992; 1(3):409-17. PMC: 2142204. DOI: 10.1002/pro.5560010313. View

17.

Singh H, Raghava G . ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001; 17(12):1236-7. DOI: 10.1093/bioinformatics/17.12.1236. View

18.

Alvarez B, Barra C, Nielsen M, Andreatta M . Computational Tools for the Identification and Interpretation of Sequence Motifs in Immunopeptidomes. Proteomics. 2018; 18(12):e1700252. PMC: 6279437. DOI: 10.1002/pmic.201700252. View

19.

Jensen K, Andreatta M, Marcatili P, Buus S, Greenbaum J, Yan Z . Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology. 2018; 154(3):394-406. PMC: 6002223. DOI: 10.1111/imm.12889. View

20.

Lovitch S, Pu Z, Unanue E . Amino-terminal flanking residues determine the conformation of a peptide-class II MHC complex. J Immunol. 2006; 176(5):2958-68. DOI: 10.4049/jimmunol.176.5.2958. View